June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Microaneurysm Turnover in eyes with mild nonproliferative diabetic retinopathy is associated with progression and development of sight-threatening complications: a 5-year longitudinal study
Author Affiliations & Notes
  • Ines Pereira Marques
    Associacao para a Investigacao Biomedica e Inovacao em Luz e Imagem, Coimbra, Coimbra, Portugal
    Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal
  • Luis Mendes
    Associacao para a Investigacao Biomedica e Inovacao em Luz e Imagem, Coimbra, Coimbra, Portugal
  • Ana Rita Santos
    Associacao para a Investigacao Biomedica e Inovacao em Luz e Imagem, Coimbra, Coimbra, Portugal
    Department of Orthoptics, School of Health, Polytechnic of Porto, Porto, Portugal
  • Diana Tavares
    Associacao para a Investigacao Biomedica e Inovacao em Luz e Imagem, Coimbra, Coimbra, Portugal
  • Maria Helena Madeira
    Associacao para a Investigacao Biomedica e Inovacao em Luz e Imagem, Coimbra, Coimbra, Portugal
    Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal
  • Conceicão F Lobo
    Associacao para a Investigacao Biomedica e Inovacao em Luz e Imagem, Coimbra, Coimbra, Portugal
    Ophthalmology, Centro Hospitalar e Universitario de Coimbra EPE Campus dos Hospitais da Universidade de Coimbra, Coimbra, Coimbra, Portugal
  • Joao Figueira
    Associacao para a Investigacao Biomedica e Inovacao em Luz e Imagem, Coimbra, Coimbra, Portugal
    Ophthalmology, Centro Hospitalar e Universitario de Coimbra EPE Campus dos Hospitais da Universidade de Coimbra, Coimbra, Coimbra, Portugal
  • Jose G Cunha-Vaz
    Associacao para a Investigacao Biomedica e Inovacao em Luz e Imagem, Coimbra, Coimbra, Portugal
    Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal
  • Footnotes
    Commercial Relationships   Ines Marques, None; Luis Mendes, None; Ana Rita Santos, None; Diana Tavares, None; Maria Madeira, None; Conceicão Lobo, None; Joao Figueira, Alimera (C), Allergan (C), Bayer (C), Bhoeringer (C), Novartis (C); Jose Cunha-Vaz, Adverum Biotechnologies (C), Alimera Sciences (C), Allergan (C), Bayer (C), Carl Zeiss Meditec (C), Gene Signal (C), Novartis (C), Oxular (C), Pfeizer (C), Roche (C), Sanofi (C), Vifor Pharma (C)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 1098. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ines Pereira Marques, Luis Mendes, Ana Rita Santos, Diana Tavares, Maria Helena Madeira, Conceicão F Lobo, Joao Figueira, Jose G Cunha-Vaz; Microaneurysm Turnover in eyes with mild nonproliferative diabetic retinopathy is associated with progression and development of sight-threatening complications: a 5-year longitudinal study. Invest. Ophthalmol. Vis. Sci. 2021;62(8):1098.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate microaneurysm turnover (MAT) as a predictive biomarker for retinopathy progression and development of sight-threatening complications, diabetic macular edema (DME) or proliferative retinopathy (PDR), in patients with type 2 diabetes and mild nonproliferative retinopathy (NPDR) in a 5-year follow-up.

Methods : A 5-year prospective, longitudinal study was designed to follow 212 patients with type 2 diabetes (T2D) and mild NPDR (ETDRS grades 20 and 35). Ophthalmological examinations of the study eye including color fundus photography (CFP) and optical coherence tomography were performed at baseline, at the first 6-months visit and annually. Outcomes were DME and/or PDR development. MAT analysis included determination of MA formation and disappearance rates, automatically assessed using the RetMarkerDR at 12-month visits. Retinopathy severity progression was evaluated using step increase in ETDRS severity grades.

Results : Of the 212 individuals with T2D and mild NPDR, 162 completed the 5-year follow up period of the study or developed an endpoint (n=25). MAT calculated on the first year showed significant association with the development of any endpoint (p = 0.0178), in particularly MA disappearance rate (p= 0.007). MAT showed also significant association with ETDRS severity worsening in the 5-year period (p= 0.0353). There were variations between MAT values in the first year of follow-up (2.04±3.18) and the 5-year (2.26±3.06; p=0.060), with a clear increase in the MA disappearance rate being observed in the last year of the study (1.50±1.93) compared with the first-year of follow-up (1.05±1.99; p=0.003).

Conclusions : MAT in eyes with T2D and mild NPDR is associated with retinopathy severity progression and development of DME and/or PDR in a period of 5-years.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×